2004. 08.02.2004. (NIH Contract)
2006. 01.09.2006. (UK Subsidiary)
2006. 12.06.2006. (Merck USA>Onco.)
2007. 11.05.2007. (and DNDi)
2009. 04.20.2009. (CEO)
2010. 04.16.2010. Hepato.>HCV
2012. 09.04.2012. Vet.>KCS
2013. 04.10. Immune Design
2013. 05.29. Antifungal Compd.
2021. 06.02. USA FDA Approval
2021. 09.22. USA Launch
2022. 12.01. USA FDA Approval
Patents
Web-Site